CompletedNot applicableNCT03702647

Ropivacaine For Post-POEM Pain Control

Studying Idiopathic achalasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lawrence Charles Hookey
Principal Investigator
Robert Bechara, M.D.
Queens University
Intervention
Ropivacaine(drug)
Enrollment
20 target
Eligibility
18 years · All sexes
Timeline
20192021

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03702647 on ClinicalTrials.gov

Other trials for Idiopathic achalasia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic achalasia

← Back to all trials